EDC, ePRO, eConsent
-
Is Your CRO’s 2023 Growth Limited By These Four Myths?
1/30/2023
Learn how CROs can leverage eClinical technology to more effectively differentiate themselves in the crowded marketplace and provide sponsors with better clinical trial support.
-
Could ePRO Be The New Standard In Health Reimbursement?
1/30/2023
Recently, early-phase protocols have been collecting patient-reported outcomes (PROs) not only to get regulatory approval but to demonstrate value to public and private payers.
-
Gain The ePRO Advantage With Real-time Data Collection
12/2/2022
Discover how ePRO automatically incorporates eCOA data into a study, improving the depth, timeliness, and accuracy of patient-reported outcomes data in the following ways.
-
How To Overcome The Problem Of The Early ePRO Oversell
11/14/2022
In this blog, explore how the approach to PROs needs to be reconsidered, given increasing regulations and trial scrutiny, the clinical need for patient-reported outcomes, and the ability to drive costs down and move off paper.
-
Start With ‘Why’ When Adopting New Tech To Support Hybrid Decentralized Trials
10/11/2022
In this article, focus on the adoption of new clinical trial technology and explore how sponsors can support sites as they select and implement technologies.
-
Notes From The Field: How eConsent Improves Clinical Trials
10/3/2022
The benefits of eConsent are multi-faceted. In this blog post, explore these advantages as they relate to participants, sites and sponsors/CROs.
-
Need Better Clinical Trial Retention? Start With eConsent
9/26/2022
When participant retention is not addressed, learn how studies need to recruit additional participants and extend trial timelines, leading ultimately to budget overruns.
-
Better eConsent Through Education Best Practices
9/23/2022
eConsent can have a positive impact on participant retention, but learn why that is only part of the challenge of meeting participant needs in a clinical trial.